Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugs.

JAC Antimicrob Resist · 2026 · PMC13058729 · PMID 41959696

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Notably, the no-prophylaxis cohort showed a trend toward better outcomes, possibly reflecting reduced microbiota disruption or lower selective pressure for resistant organisms.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.